Diltiazem

Diltiazem vs. placebo for coronary vasomotor dysfunction in patients with angina and nonobstructive CAD.

WASHINGTON — In the first randomized trial of a therapy for treatment of patients with angina and nonobstructive CAD, diltiazem did not improve coronary vasomotor dysfunction compared with placebo.